ACTR-61. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Authors: Isabel Arrillaga-Romany, Solmaz Sahebjam, David Picconi, Jian Campian, Pierre Giglio, Jan Drappatz, Robert Aiken, John Villano, Eudocia Lee, Mary Welch, Benjamin Ellingson, Douglas Ney, Kevin Becker, Alona Muzikansky, Biswajit Das, Elizabeth Swisher, Andrew Nixon, Chris Karlovich, P Mickey Williams, S Percy Ivy, Tracy Batchelor, Elizabeth Gerstner

Published: 2019-11-11

DOI: 10.1093/neuonc/noz175.103

Source: Full article


Abstract

Abstract